Discovery Life Sciences is a global leader in biospecimens and specialty lab services, enabling the discovery and development of therapeutics and diagnostics that improve patient outcomes. Our extensive portfolio of normal and diseased human biospecimens, cellular starting materials, and preclinical ADME-tox products and services accelerates research with high-quality, highly characterized materials, complemented by expertise in cell biology.
Our comprehensive suite of lab services, including molecular pathology, genomics, proteomics, and flow cytometry, delivers critical data and insights for biomarker discovery across the full spectrum of retrospective and prospective clinical trials, from assay development and validation through Phase 3 and post-approval pathologist training. With a vision to be the most trusted partner in life science research and clinical development, Discovery Life Sciences is committed to advancing scientific research and transforming lives.
